Anti-atherosclerotic Effects of Spice-Derived Phytochemicals

Barquera, S.; Pedroza-Tobías, A.; Medina, C.; Hernández-Barrera, L.; Bibbins-Domingo, K.; Lozano, R.; Moran, A.E. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch. Med. Res., 2015, 46(5), 328-338.
[http://dx.doi.org/10.1016/j.arcmed.2015.06.006] [PMID: 26135634]

Rai, V.; Jadhav, G.P. Role of transcription factors in regulating development and progression of atherosclerosis. Annals Vasc. Med. Surg., 2019, 2(1), 1-5.

Roth, G.A.; Johnson, C.; Abajobir, A.; Abd-Allah, F.; Abera, S.F.; Abyu, G.; Ahmed, M.; Aksut, B.; Alam, T.; Alam, K.; Alla, F.; Alvis-Guzman, N.; Amrock, S.; Ansari, H.; Ärnlöv, J.; Asayesh, H.; Atey, T.M.; Avila-Burgos, L.; Awasthi, A.; Banerjee, A.; Barac, A.; Bärnighausen, T.; Barregard, L.; Bedi, N.; Belay Ketema, E.; Bennett, D.; Berhe, G.; Bhutta, Z.; Bitew, S.; Carapetis, J.; Carrero, J.J.; Malta, D.C.; Castañeda-Orjuela, C.A.; Castillo-Rivas, J.; Catalá-López, F.; Choi, J.Y.; Christensen, H.; Cirillo, M.; Cooper, L., Jr; Criqui, M.; Cundiff, D.; Damasceno, A.; Dandona, L.; Dandona, R.; Davletov, K.; Dharmaratne, S.; Dorairaj, P.; Dubey, M.; Ehrenkranz, R.; El Sayed Zaki, M.; Faraon, E.J.A.; Esteghamati, A.; Farid, T.; Farvid, M.; Feigin, V.; Ding, E.L.; Fowkes, G.; Gebrehiwot, T.; Gillum, R.; Gold, A.; Gona, P.; Gupta, R.; Habtewold, T.D.; Hafezi-Nejad, N.; Hailu, T.; Hailu, G.B.; Hankey, G.; Hassen, H.Y.; Abate, K.H.; Havmoeller, R.; Hay, S.I.; Horino, M.; Hotez, P.J.; Jacobsen, K.; James, S.; Javanbakht, M.; Jeemon, P.; John, D.; Jonas, J.; Kalkonde, Y.; Karimkhani, C.; Kasaeian, A.; Khader, Y.; Khan, A.; Khang, Y.H.; Khera, S.; Khoja, A.T.; Khubchandani, J.; Kim, D.; Kolte, D.; Kosen, S.; Krohn, K.J.; Kumar, G.A.; Kwan, G.F.; Lal, D.K.; Larsson, A.; Linn, S.; Lopez, A.; Lotufo, P.A.; El Razek, H.M.A.; Malekzadeh, R.; Mazidi, M.; Meier, T.; Meles, K.G.; Mensah, G.; Meretoja, A.; Mezgebe, H.; Miller, T.; Mirrakhimov, E.; Mohammed, S.; Moran, A.E.; Musa, K.I.; Narula, J.; Neal, B.; Ngalesoni, F.; Nguyen, G.; Obermeyer, C.M.; Owolabi, M.; Patton, G.; Pedro, J.; Qato, D.; Qorbani, M.; Rahimi, K.; Rai, R.K.; Rawaf, S.; Ribeiro, A.; Safiri, S.; Salomon, J.A.; Santos, I.; Santric Milicevic, M.; Sartorius, B.; Schutte, A.; Sepanlou, S.; Shaikh, M.A.; Shin, M.J.; Shishehbor, M.; Shore, H.; Silva, D.A.S.; Sobngwi, E.; Stranges, S.; Swaminathan, S.; Tabarés-Seisdedos, R.; Tadele Atnafu, N.; Tesfay, F.; Thakur, J.S.; Thrift, A.; Topor-Madry, R.; Truelsen, T.; Tyrovolas, S.; Ukwaja, K.N.; Uthman, O.; Vasankari, T.; Vlassov, V.; Vollset, S.E.; Wakayo, T.; Watkins, D.; Weintraub, R.; Werdecker, A.; Westerman, R.; Wiysonge, C.S.; Wolfe, C.; Workicho, A.; Xu, G.; Yano, Y.; Yip, P.; Yonemoto, N.; Younis, M.; Yu, C.; Vos, T.; Naghavi, M.; Murray, C. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J. Am. Coll. Cardiol., 2017, 70(1), 1-25.
[http://dx.doi.org/10.1016/j.jacc.2017.04.052] [PMID: 28527533]

Robinson, J.G.; Williams, K.J.; Gidding, S.; Borén, J.; Tabas, I.; Fisher, E.A.; Packard, C.; Pencina, M.; Fayad, Z.A.; Mani, V.; Rye, K.A.; Nordestgaard, B.G.; Tybjærg-Hansen, A.; Douglas, P.S.; Nicholls, S.J.; Pagidipati, N.; Sniderman, A. Eradicating the burden of atherosclerotic cardiovascular disease by lowering apolipoprotein B lipoproteins earlier in life. J. Am. Heart Assoc., 2018, 7(20), 1-20.
[http://dx.doi.org/10.1161/JAHA.118.009778] [PMID: 30371276]

Aziz, M.; Yadav, K.S. Pathogenesis of atherosclerosis. Med Clin Rev., 2016, 2(3), 1-6.
[http://dx.doi.org/10.21767/2471-299X.100031 ]

Insull, W., Jr The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am. J. Med., 2009, 122(1)(Suppl.), S3-S14.
[http://dx.doi.org/10.1016/j.amjmed.2008.10.013]] [PMID: 19110086]

Kunnumakkara, A.B.; Sailo, B.L.; Banik, K.; Harsha, C.; Prasad, S.; Gupta, S.C.; Bharti, A.C.; Aggarwal, B.B. Chronic diseases, inflammation, and spices: how are they linked? J. Transl. Med., 2018, 16(1), 14.
[http://dx.doi.org/10.1186/s12967-018-1381-2] [PMID: 29370858]

Tsui, P.F.; Lin, C.S.; Ho, L.J.; Lai, J.H. Spices and atherosclerosis. Nutrients, 2018, 10(11), 1724.
[http://dx.doi.org/10.3390/nu10111724] [PMID: 30423840]

Vasanthi, H.R.; Parameswari, R.P. Indian spices for healthy heart - an overview. Curr. Cardiol. Rev., 2010, 6(4), 274-279.
[http://dx.doi.org/10.2174/157340310793566172] [PMID: 22043203]

Aquila, G.; Marracino, L.; Martino, V.; Calabria, D.; Campo, G.; Caliceti, C.; Rizzo, P. The use of nutraceuticals to counteract atherosclerosis: the role of the notch pathway. Oxid. Med. Cell. Longev., 2019, 20195470470
[http://dx.doi.org/10.1155/2019/5470470] [PMID: 31915510]

Chen, F.Y.; Zhou, J.; Guo, N.; Ma, W.G.; Huang, X.; Wang, H.; Yuan, Z.Y. Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis. Biochem. Biophys. Res. Commun., 2015, 467(4), 872-878.
[http://dx.doi.org/10.1016/j.bbrc.2015.10.051] [PMID: 26471308]

Yang, X.; He, T.; Han, S.; Zhang, X.; Sun, Y.; Xing, Y.; Shang, H. The role of traditional chinese medicine in the regulation of oxidative stress in treating coronary heart disease. Oxid. Med. Cell. Longev., 2019, 20193231424
[http://dx.doi.org/10.1155/2019/3231424] [PMID: 30918578]

Razak, S.I.; Anwar Hamzah, M.S.; Yee, F.C.; Kadir, M.R.; Nayan, N.H. A review on medicinal properties of saffron toward major diseases. J. Herbs Spices Med. Plants, 2017, 23(2), 98-116.
[http://dx.doi.org/10.1080/10496475.2016.1272522]

Basith, S.; Cui, M.; Hong, S.; Choi, S. Harnessing the therapeutic potential of capsaicin and its analogues in pain and other diseases. Molecules, 2016, 21(8), 966.
[http://dx.doi.org/10.3390/molecules21080966] [PMID: 27455231]

McCarty, M.F.; DiNicolantonio, J.J.; O’Keefe, J.H. Capsaicin may have important potential for promoting vascular and metabolic health. Open Heart, 2015, 2(1)e000262
[http://dx.doi.org/10.1136/openhrt-2015-000262] [PMID: 26113985]

Luqman, S.; Rizvi, S.I. Protection of lipid peroxidation and carbonyl formation in proteins by capsaicin in human erythrocytes subjected to oxidative stress. Phytother. Res., 2006, 20(4), 303-306.
[http://dx.doi.org/10.1002/ptr.1861] [PMID: 16557614]

Wang, Q.; Ma, S.; Li, D.; Zhang, Y.; Tang, B.; Qiu, C.; Yang, Y.; Yang, D. Dietary capsaicin ameliorates pressure overload-induced cardiac hypertrophy and fibrosis through the transient receptor potential vanilloid type 1. Am. J. Hypertens., 2014, 27(12), 1521-1529.
[http://dx.doi.org/10.1093/ajh/hpu068] [PMID: 24858305]

Sun, F.; Xiong, S.; Zhu, Z. Dietary capsaicin protects cardiometabolic organs from dysfunction. Nutrients, 2016, 8(5), 1-13.
[http://dx.doi.org/10.3390/nu8050174] [PMID: 27120617]

Kempaiah, R.K.; Manjunatha, H.; Srinivasan, K. Protective effect of dietary capsaicin on induced oxidation of low-density lipoprotein in rats. Mol. Cell. Biochem., 2005, 275(1-2), 7-13.
[http://dx.doi.org/10.1007/s11010-005-7643-3] [PMID: 16335782]

Kang, J.H.; Kim, C.S.; Han, I.S.; Kawada, T.; Yu, R. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett., 2007, 581(23), 4389-4396.
[http://dx.doi.org/10.1016/j.febslet.2007.07.082] [PMID: 17719033]

Tang, J.; Luo, K.; Li, Y.; Chen, Q.; Tang, D.; Wang, D.; Xiao, J. Capsaicin attenuates LPS-induced inflammatory cytokine production by upregulation of LXRα. Int. Immunopharmacol., 2015, 28(1), 264-269.
[http://dx.doi.org/10.1016/j.intimp.2015.06.007] [PMID: 26093270]

Hu, Y.W.; Ma, X.; Huang, J.L.; Mao, X.R.; Yang, J.Y.; Zhao, J.Y.; Li, S.F.; Qiu, Y.R.; Yang, J.; Zheng, L.; Wang, Q. Dihydrocapsaicin attenuates plaque formation through a PPARγ/LXRα pathway in ApoE−/− mice fed a high-fat/high-cholesterol diet. PLoS One, 2013, 8(6)e66876
[http://dx.doi.org/10.1371/journal.pone.0066876] [PMID: 23840542]

Zhao, J.J.; Hu, Y.W.; Huang, C.; Ma, X.; Kang, C.M.; Zhang, Y.; Guo, F.X.; Lu, J.B.; Xiu, J.C.; Qiu, Y.R.; Sha, Y.H.; Gao, J.J.; Wang, Y.C.; Li, P.; Xu, B.M.; Zheng, L.; Wang, Q. Dihydrocapsaicin suppresses proinflammatory cytokines expression by enhancing nuclear factor IA in a NF-κB-dependent manner. Arch. Biochem. Biophys., 2016, 604, 27-35.
[http://dx.doi.org/10.1016/j.abb.2016.06.002] [PMID: 27267730]

Zhao, J-Y.; Hu, Y-W.; Li, S-F.; Hu, Y-R.; Ma, X.; Wu, S-G.; Wang, Y-C.; Gao, J-J.; Sha, Y-H.; Zheng, L.; Wang, Q. Dihydrocapsaicin down-regulates apoM expression through inhibiting Foxa2 expression and enhancing LXR α expression in HepG2 cells. Lipids Health Dis., 2014, 13(50), 1-8.
[http://dx.doi.org/10.1186/1476-511x-13-50] [PMID: 24642298]

Yu, Y-M.; Lin, H-C.; Chang, W-C. Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9. Br. J. Nutr., 2008, 100(4), 731-738.
[http://dx.doi.org/10.1017/S0007114508923710] [PMID: 18298869]

Kuo, C-F.; Su, J-D.; Chiu, C-H.; Peng, C-C.; Chang, C-H.; Sung, T-Y.; Huang, S-H.; Lee, W-C.; Chyau, C-C. Anti-inflammatory effects of supercritical carbon dioxide extract and its isolated carnosic acid from Rosmarinus officinalis leaves. J. Agric. Food Chem., 2011, 59(8), 3674-3685.
[http://dx.doi.org/10.1021/jf104837w] [PMID: 21375325]

Arranz, E.; Jaime, L.; Garc, M.R.; Fornari, T.; Reglero, G.; Santoyo, S. Anti-inflammatory activity of rosemary extracts obtained by supercritical carbon dioxide enriched in carnosic acid and carnosol. Int. J. Food Sci. Technol., 2015, 50, 674-681.
[http://dx.doi.org/10.1111/ijfs.12656]

Yu, Y.M.; Lin, C.H.; Chan, H.C.; Tsai, H.D. Carnosic acid reduces cytokine-induced adhesion molecules expression and monocyte adhesion to endothelial cells. Eur. J. Nutr., 2009, 48(2), 101-106.
[http://dx.doi.org/10.1007/s00394-008-0768-x] [PMID: 19142568]

Lee, K.P.; Sudjarwo, G.W.; Jung, S.H.; Lee, D.; Lee, D.Y.; Lee, G.B.; Baek, S.; Kim, D.Y.; Lee, H.M.; Kim, B.; Kwon, S.C.; Won, K.J. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells. Atherosclerosis, 2015, 240(2), 367-373.
[http://dx.doi.org/10.1016/j.atherosclerosis.2015.03.038] [PMID: 25875388]

Chen, Y.; Ba, L.; Huang, W.; Liu, Y.; Pan, H.; Mingyao, E.; Shi, P.; Wang, Y.; Li, S.; Qi, H.; Sun, H.; Cao, Y. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways. Eur. J. Pharmacol., 2017, 796, 90-100.
[http://dx.doi.org/10.1016/j.ejphar.2016.11.053] [PMID: 27916558]

Spalletta, S.; Flati, V.; Toniato, E.; Di Gregorio, J.; Marino, A.; Pierdomenico, L.; Marchisio, M.; D’Orazi, G.; Cacciatore, I.; Robuffo, I. Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression. PLoS One, 2018, 13(11)e0206894
[http://dx.doi.org/10.1371/journal.pone.0206894] [PMID: 30418986]

Zhou, H.; Yu, X.; Zhou, G. Carvacrol protects against tumor necrosis factor-mediated inflammation in vascular smooth muscle cell through NF-κB pathway. Int. J. Clin. Exp. Pathol., 2017, 10(1), 206-214.

Ezhumalai, M.; Ashokkumar, N.; Pugalendi, K.V. RETRACTED: Combination of carvacrol and rosiglitazone ameliorates high fat diet induced changes in lipids and inflammatory markers in C57BL/6J mice. Biochimie, 2015, 110, 129-136.
[http://dx.doi.org/10.1016/j.biochi.2014.12.005] [PMID: 25527325]

Muhammad, D.R.; Dewettinck, K. Cinnamon and its derivatives as potential ingredient in functional food—a review. Int. j. Food prop., 2017, 20(2), 2237-2263.

Li, W.; Zhi, W.; Zhao, J.; Yao, Q.; Liu, F.; Niu, X. Cinnamaldehyde protects VSMCs against ox-LDL-induced proliferation and migration through S arrest and inhibition of p38, JNK/MAPKs and NF-κB. Vascul. Pharmacol., 2018, 108, 57-66.
[http://dx.doi.org/10.1016/j.vph.2018.05.005] [PMID: 29777873]

Liao, B.C.; Hsieh, C.W.; Liu, Y.C.; Tzeng, T.T.; Sun, Y.W.; Wung, B.S. Cinnamaldehyde inhibits the tumor necrosis factor-α-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2. Toxicol. Appl. Pharmacol., 2008, 229(2), 161-171.
[http://dx.doi.org/10.1016/j.taap.2008.01.021] [PMID: 18304597]

Dorri, M.; Hashemitabar, S.; Hosseinzadeh, H. Cinnamon (Cinnamomum zeylanicum) as an antidote or a protective agent against natural or chemical toxicities: a review. Drug Chem. Toxicol., 2018, 41(3), 338-351.
[http://dx.doi.org/10.1080/01480545.2017.1417995] [PMID: 29319361]

Buglak, N.E.; Jiang, W.; Bahnson, E.S.M. Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats. Redox Biol., 2018, 19, 166-178.
[http://dx.doi.org/10.1016/j.redox.2018.08.013] [PMID: 30172101]

Li, W.; Zhi, W.; Zhao, J.; Li, W.; Zang, L.; Liu, F.; Niu, X. Cinnamaldehyde attenuates atherosclerosis via targeting the IκB/NF-κB signaling pathway in high fat diet-induced ApoE-/- mice. Food Funct., 2019, 10(7), 4001-4009.
[http://dx.doi.org/10.1039/C9FO00396G] [PMID: 31210194]

Jin, Y.H.; Kim, S.A. 2-Methoxycinnamaldehyde inhibits the TNF-α-induced proliferation and migration of human aortic smooth muscle cells. Int. J. Mol. Med., 2017, 39(1), 191-198.
[http://dx.doi.org/10.3892/ijmm.2016.2818] [PMID: 27922672]

Kwon, J.Y.; Hong, S.H.; Park, S.D.; Ahn, S.G.; Yoon, J.H.; Kwon, B.M.; Kim, S.A. 2′-Benzoyloxycinnamaldehyde inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells via regulation of AP-1 pathway. Eur. J. Pharmacol., 2012, 696(1-3), 179-186.
[http://dx.doi.org/10.1016/j.ejphar.2012.09.027] [PMID: 23036374]

Nour, O.A.A.; Shehatou, G.S.G.; Rahim, M.A.; El-Awady, M.S.; Suddek, G.M. Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits. Naunyn Schmiedebergs Arch. Pharmacol., 2018, 391(11), 1203-1219.
[http://dx.doi.org/10.1007/s00210-018-1547-8] [PMID: 30058017]

Min, K.J.; Um, H.J.; Cho, K.H.; Kwon, T.K. Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. Food Chem. Toxicol., 2013, 58, 77-85.
[http://dx.doi.org/10.1016/j.fct.2013.04.008] [PMID: 23603106]

Sahebkar, A. Molecular mechanisms for curcumin benefits against ischemic injury. Fertil. Steril., 2010, 94(5), e75-e76.
[http://dx.doi.org/10.1016/j.fertnstert.2010.07.1071] [PMID: 20797714]

Panahi, Y.; Kianpour, P.; Mohtashami, R.; Jafari, R.; Simental-Mendía, L.E.; Sahebkar, A. Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug Res. (Stuttg.), 2017, 67(4), 244-251.
[http://dx.doi.org/10.1055/s-0043-100019] [PMID: 28158893]

Iranshahi, M.; Sahebkar, A.; Takasaki, M.; Konoshima, T.; Tokuda, H. Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. Eur. J. Cancer Prev., 2009, 18(5), 412-415.
[http://dx.doi.org/10.1097/CEJ.0b013e32832c389e] [PMID: 19531956]

Rezaee, R.; Momtazi, A.A.; Monemi, A.; Sahebkar, A. Curcumin: a potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacol. Res., 2017, 117, 218-227.
[http://dx.doi.org/10.1016/j.phrs.2016.12.037] [PMID: 28042086]

Abdollahi, E.; Momtazi, A.A.; Johnston, T.P.; Sahebkar, A. Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: a nature-made jack-of-all-trades? J. Cell. Physiol., 2018, 233(2), 830-848.
[http://dx.doi.org/10.1002/jcp.25778] [PMID: 28059453]

Karimian, M.S.; Pirro, M.; Majeed, M.; Sahebkar, A. Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine Growth Factor Rev., 2017, 33, 55-63.
[http://dx.doi.org/10.1016/j.cytogfr.2016.10.001] [PMID: 27743775]

Panahi, Y.; Hosseini, M.S.; Khalili, N.; Naimi, E.; Simental-Mendía, L.E.; Majeed, M.; Sahebkar, A. Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. Biomed. Pharmacother., 2016, 82, 578-582.
[http://dx.doi.org/10.1016/j.biopha.2016.05.037] [PMID: 27470399]

Mollazadeh, H.; Cicero, A.F.G.; Blesso, C.N.; Pirro, M.; Majeed, M.; Sahebkar, A. Immune modulation by curcumin: The role of interleukin-10. Crit. Rev. Food Sci. Nutr., 2019, 59(1), 89-101.
[http://dx.doi.org/10.1080/10408398.2017.1358139] [PMID: 28799796]

Ricci, C.; Ferri, N. Naturally occurring PDGF receptor inhibitors with potential anti-atherosclerotic properties. Vascul. Pharmacol., 2015, 70, 1-7.
[http://dx.doi.org/10.1016/j.vph.2015.02.002] [PMID: 25737405]

Zingg, J.M.; Hasan, S.T.; Cowan, D.; Ricciarelli, R.; Azzi, A.; Meydani, M. Regulatory effects of curcumin on lipid accumulation in monocytes/macrophages. J. Cell. Biochem., 2012, 113(3), 833-840.
[http://dx.doi.org/10.1002/jcb.23411] [PMID: 22021079]

Kapakos, G.; Youreva, V.; Srivastava, A.K. Cardiovascular protection by curcumin: molecular aspects. Indian J. Biochem. Biophys., 2012, 49(5), 306-315.
[PMID: 23259317]

Zingg, J.M.; Hasan, S.T.; Meydani, M. Molecular mechanisms of hypolipidemic effects of curcumin. Biofactors, 2013, 39(1), 101-121.
[http://dx.doi.org/10.1002/biof.1072] [PMID: 23339042]

Zhou, Y.; Zhang, T.; Wang, X.; Wei, X.; Chen, Y.; Guo, L.; Zhang, J.; Wang, C. Curcumin modulates macrophage polarization through the inhibition of the toll-like receptor 4 expression and its signaling pathways. Cell. Physiol. Biochem., 2015, 36(2), 631-641.
[http://dx.doi.org/10.1159/000430126] [PMID: 25998190]

Zingg, J.M.; Hasan, S.T.; Nakagawa, K.; Canepa, E.; Ricciarelli, R.; Villacorta, L.; Azzi, A.; Meydani, M. Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression. Biofactors, 2017, 43(1), 42-53.
[http://dx.doi.org/10.1002/biof.1307] [PMID: 27355903]

Khalil, A.A. ur Rahman, U.; Khan, M.R.; Sahar, A.; Mehmood, T.; Khan, M. Essential oil eugenol: sources, extraction techniques and nutraceutical perspectives. RSC Advances, 2017, 7(52), 32669-32681.
[http://dx.doi.org/10.1039/C7RA04803C]

Narasimhulu, C.A.; Vardhan, S. Therapeutic potential of Ocimum tenuiflorum as MPO inhibitor with implications for atherosclerosis prevention. J. Med. Food, 2015, 18(5), 507-515.
[http://dx.doi.org/10.1089/jmf.2014.0125] [PMID: 25764050]

Suanarunsawat, T.; Ayutthaya, W.D.; Songsa, T.; Rattanamahaphoom, J. Anti-lipidemic actions of essential oil extracted from Ocimum sanctum L. leaves in rats fed with high cholesterol diet. J. Appl. Biomed., 2009, 7(1), 45-53.
[http://dx.doi.org/10.32725/jab.2009.004]]

Huang, M-Z.; Lu, X-R.; Yang, Y-J.; Liu, X-W.; Qin, Z.; Li, J-Y. Cellular metabolomics reveal the mechanism underlying the anti-atherosclerotic effects of aspirin eugenol ester on vascular endothelial dysfunction. Int. J. Mol. Sci., 2019, 20(13), 3165.
[http://dx.doi.org/10.3390/ijms20133165] [PMID: 31261711]

Ma, N.; Yang, Y.; Liu, X.; Kong, X.; Li, S.; Qin, Z.; Jiao, Z.; Li, J. UPLC-Q-TOF/MS-based metabonomic studies on the intervention effects of aspirin eugenol ester in atherosclerosis hamsters. Sci. Rep., 2017, 7(1), 10544.
[http://dx.doi.org/10.1038/s41598-017-11422-7] [PMID: 28874840]

Ma, N.; Yang, G-Z.; Liu, X-W.; Yang, Y-J.; Mohamed, I.; Liu, G-R.; Li, J-Y. Impact of aspirin eugenol ester on cyclooxygenase-1, cyclooxygenase-2, c-reactive protein, prothrombin and arachidonate 5-lipoxygenase in healthy rats. Iran. J. Pharm. Res., 2017, 16(4), 1443-1451.
[PMID: 29552053]

Rusmana, D.; Elisabeth, M.; Widowati, W.; Fauziah, N.; Maesaroh, M. Inhibition of inflammatory agent production by ethanol extract and eugenol of Syzygium aromaticum (L.) flower bud (clove) in LPS-stimulated Raw 264.7 cells. Res. J. Med. Plant, 2015, 9(6), 264-274.
[http://dx.doi.org/10.3923/rjmp.2015.264.274]

Naderi, G.A.; Asgary, S.; Ani, M.; Sarraf-Zadegan, N.; Safari, M.R. Effect of some volatile oils on the affinity of intact and oxidized low-density lipoproteins for adrenal cell surface receptors. Mol. Cell. Biochem., 2004, 267(1-2), 59-66.
[http://dx.doi.org/10.1023/B:MCBI.0000049365.60694.81] [PMID: 15663186]

Karam, I.; Yang, Y.J.; Li, J.Y. Hyperlipidemia background and progress. SM Atheroscler. J., 2017, 1(1), 1003.

Liu, C.; Xie, T.; He, C.; Xu, L.; Liu, Z. Study on the interaction of gingerol and Sudan dye. Adv. Mater. Res., 2011, 236, 2894-2898.
[http://dx.doi.org/10.4028/www.scientific.net/AMR.236-238.2894 ]

Lee, Y.J.; Jang, Y.N.; Han, Y.M.; Kim, H.M.; Seo, H.S. 6-gingerol normalizes the expression of biomarkers related to hypertension via PPARδ in HUVECs, HEK293, and differentiated 3T3-L1 cells. PPAR Res., 2018, 20186485064
[http://dx.doi.org/10.1155/2018/6485064] [PMID: 30643517]

Wang, S.; Tian, M.; Yang, R.; Jing, Y.; Chen, W.; Wang, J.; Zheng, X.; Wang, F. 6-Gingerol ameliorates behavioral changes and atherosclerotic lesions in ApoE−/− mice exposed to chronic mild stress. Cardiovasc. Toxicol., 2018, 18(5), 420-430.
[http://dx.doi.org/10.1007/s12012-018-9452-4] [PMID: 29605868]

Kamato, D.; Babaahmadi Rezaei, H.; Getachew, R.; Thach, L.; Guidone, D.; Osman, N.; Roufogalis, B.; Duke, C.C.; Tran, V.H.; Zheng, W.; Little, P.J. (S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells. J. Pharm. Pharmacol., 2013, 65(7), 1026-1036.
[http://dx.doi.org/10.1111/jphp.12060] [PMID: 23738730]

Yusof, Y.A.M. Gingerol and its role in chronic diseases. Adv. Exp. Med. Biol., 2016, 929, 177-207.
[http://dx.doi.org/10.1007/978-3-319-41342-6_8] [PMID: 27771925]

Seo, C.S.; Kim, O.S.; Kim, Y.; Shin, H.K. Simultaneous quantification and inhibitory effect on LDL oxidation of the traditional Korean medicine, Leejung-tang. BMC Complement. Altern. Med., 2014, 14(1), 3.
[http://dx.doi.org/10.1186/1472-6882-14-3] [PMID: 24383717 ]

Mao, Z.; Gan, C.; Zhu, J.; Ma, N.; Wu, L.; Wang, L.; Wang, X. Anti-atherosclerotic activities of flavonoids from the flowers of Helichrysum arenarium L. MOENCH through the pathway of anti-inflammation. Bioorg. Med. Chem. Lett., 2017, 27(12), 2812-2817.
[http://dx.doi.org/10.1016/j.bmcl.2017.04.076] [PMID: 28479197]

Kleemann, R.; Verschuren, L.; Morrison, M.; Zadelaar, S.; van Erk, M.J.; Wielinga, P.Y.; Kooistra, T. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis, 2011, 218(1), 44-52.
[http://dx.doi.org/10.1016/j.atherosclerosis.2011.04.023] [PMID: 21601209]

Luo, Y.; Shang, P.; Li, D.; Chapple, S.J. Luteolin: a flavonoid that has multiple cardio-protective effects and its molecular mechanisms. Front. Pharmacol., 2017, 8, 692.
[http://dx.doi.org/10.3389/fphar.2017.00692] [PMID: 29056912]

Bhaskar, S.; Sudhakaran, P.R.; Helen, A. Quercetin attenuates atherosclerotic inflammation and adhesion molecule expression by modulating TLR-NF-κB signaling pathway. Cell. Immunol., 2016, 310, 131-140.
[http://dx.doi.org/10.1016/j.cellimm.2016.08.011] [PMID: 27585526]

Kong, L.; Luo, C.; Li, X.; Zhou, Y.; He, H. The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits. Lipids Health Dis., 2013, 12(115), 115.
[http://dx.doi.org/10.1186/1476-511X-12-115] [PMID: 23895132]

Del Rio, D.; Costa, L.G.; Lean, M.E.J.; Crozier, A. Polyphenols and health: what compounds are involved? Nutr. Metab. Cardiovasc. Dis., 2010, 20(1), 1-6.
[http://dx.doi.org/10.1016/j.numecd.2009.05.015] [PMID: 19713090]

Millar, C.L.; Duclos, Q.; Blesso, C.N. Effects of dietary flavonoids on reverse cholesterol transport, HDL metabolism, and HDL function. Adv. Nutr., 2017, 8(2), 226-239.
[http://dx.doi.org/10.3945/an.116.014050] [PMID: 28298268]

Calabriso, N.; Scoditti, E.; Massaro, M.; Pellegrino, M.; Storelli, C.; Ingrosso, I.; Giovinazzo, G.; Carluccio, M.A. Multiple anti-inflammatory and anti-atherosclerotic properties of red wine polyphenolic extracts: differential role of hydroxycinnamic acids, flavonols and stilbenes on endothelial inflammatory gene expression. Eur. J. Nutr., 2016, 55(2), 477-489.
[http://dx.doi.org/10.1007/s00394-015-0865-6] [PMID: 25724173]

Nickel, T.; Hanssen, H.; Sisic, Z.; Pfeiler, S.; Summo, C.; Schmauss, D.; Hoster, E.; Weis, M. Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. Eur. J. Nutr., 2011, 50(3), 163-172.
[http://dx.doi.org/10.1007/s00394-010-0125-8] [PMID: 20652710]

Thilakarathna, S.H.; Rupasinghe, H.P.V. Anti-atherosclerotic effects of fruit bioactive compounds : a review of current scientific evidence. Can. J. Plant Sci., 2012, 92, 407-419.
[http://dx.doi.org/10.4141/cjps2011-090]

Hung, C.H.; Chan, S.H.; Chu, P.M.; Tsai, K.L. Quercetin is a potent anti-atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation. Mol. Nutr. Food Res., 2015, 59(10), 1905-1917.
[http://dx.doi.org/10.1002/mnfr.201500144] [PMID: 26202455]

Lee, J.J.; Lee, J.H.; Gu, M.J.; Han, J.H.; Cho, W.K.; Ma, J.Y. Agastache rugosa Kuntze extract, containing the active component rosmarinic acid, prevents atherosclerosis through up-regulation of the cyclin-dependent kinase inhibitors p21WAF1/CIP1 and p27KIP1. J. Funct. Foods, 2017, 30, 30-38.
[http://dx.doi.org/10.1016/j.jff.2016.12.025]

Naito, Y.; Oka, S.; Yoshikawa, T. Inflammatory response in the pathogenesis of atherosclerosis and its prevention by rosmarinic acid, a functional ingredient of rosemary. Food Fact. Hea. Pro. Dis. Prev., 2003, 851, 208-212.
[http://dx.doi.org/10.1021/bk-2003-0851.ch018]

Huang, S-S.; Zheng, R-L. Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett., 2006, 239(2), 271-280.
[http://dx.doi.org/10.1016/j.canlet.2005.08.025] [PMID: 16239062]

Ferreira, L.G.; Celotto, A.C.; Capellini, V.K.; Albuquerque, A.A.S.; de Nadai, T.R.; de Carvalho, M.T.M.; Evora, P.R.B. Does rosmarinic acid underestimate as an experimental cardiovascular drug? Acta Cir. Bras., 2013, 28(1), 83-87.
[http://dx.doi.org/10.1590/S0102-86502013001300016] [PMID: 23381830]

Lin, C-H.; Shen, M-L.; Zhou, N.; Lee, C-C.; Kao, S-T.; Wu, D.C. Protective effects of the polyphenol sesamin on allergen-induced T(H)2 responses and airway inflammation in mice. PLoS One, 2014, 9(4)e96091
[http://dx.doi.org/10.1371/journal.pone.0096091] [PMID: 24755955]

Loke, W.M.; Proudfoot, J.M.; Hodgson, J.M.; McKinley, A.J.; Hime, N.; Magat, M.; Stocker, R.; Croft, K.D. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol., 2010, 30(4), 749-757.
[http://dx.doi.org/10.1161/ATVBAHA.109.199687] [PMID: 20093625]

Liu, N.; Wu, C.; Sun, L.; Zheng, J.; Guo, P. Sesamin enhances cholesterol efflux in RAW264.7 macrophages. Molecules, 2014, 19(6), 7516-7527.
[http://dx.doi.org/10.3390/molecules19067516] [PMID: 24914897]

Narasimhulu, C.A.; Burge, K.Y.; Doomra, M.; Riad, A.; Parthasarathy, S. Primary prevention of atherosclerosis by pretreatment of low-density lipoprotein receptor knockout mice with sesame oil and its aqueous components. Sci. Rep., 2018, 8(1), 12270.
[http://dx.doi.org/10.1038/s41598-018-29849-x] [PMID: 30115989]

Jun, H.J.; Hoang, M.H.; Yeo, S.K.; Jia, Y.; Lee, S.J. Induction of ABCA1 and ABCG1 expression by the liver X receptor modulator cineole in macrophages. Bioorg. Med. Chem. Lett., 2013, 23(2), 579-583.
[http://dx.doi.org/10.1016/j.bmcl.2012.11.012] [PMID: 23246324]

Linghu, K.; Lin, D.; Yang, H.; Xu, Y.; Zhang, Y.; Tao, L.; Chen, Y.; Shen, X. Ameliorating effects of 1,8-cineole on LPS-induced human umbilical vein endothelial cell injury by suppressing NF-κB signaling in vitro. Eur. J. Pharmacol., 2016, 789, 195-201.
[http://dx.doi.org/10.1016/j.ejphar.2016.07.039] [PMID: 27455900]

Cho, K.H. 1,8-cineole protected human lipoproteins from modification by oxidation and glycation and exhibited serum lipid-lowering and anti-inflammatory activity in zebrafish. BMB Rep., 2012, 45(10), 565-570.
[http://dx.doi.org/10.5483/BMBRep.2012.45.10.044] [PMID: 23101510]

Linghu, K-G.; Wu, G-P.; Fu, L-Y.; Yang, H.; Li, H-Z.; Chen, Y.; Yu, H.; Tao, L.; Shen, X-C. 1, 8-Cineole ameliorates LPS-Induced vascular endothelium dysfunction in mice via PPAR-γ dependent regulation of NF-κB. Front. Pharmacol., 2019, 10, 178.
[http://dx.doi.org/10.3389/fphar.2019.00178] [PMID: 30930772]

de Andrade, T.U.; Brasil, G.A.; Endringer, D.C.; da Nóbrega, F.R.; de Sousa, D.P. Cardiovascular activity of the chemical constituents of essential oils. Molecules, 2017, 22(9), 1539.
[http://dx.doi.org/10.3390/molecules22091539] [PMID: 28926969]

Xi, L.; Qian, Z. Pharmacological properties of crocetin and crocin (digentiobiosyl ester of crocetin) from saffron. Nat. Prod. Commun., 2006, 1(1), 65-75.
[http://dx.doi.org/10.1177/1934578X0600100112]

Tong, L.; Qi, G. Crocin prevents platelet derived growth factor BB induced vascular smooth muscle cells proliferation and phenotypic switch. Mol. Med. Rep., 2018, 17(6), 7595-7602.
[http://dx.doi.org/10.3892/mmr.2018.8854] [PMID: 29620234]

Alavizadeh, S.H.; Hosseinzadeh, H. Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem. Toxicol., 2014, 64, 65-80.
[http://dx.doi.org/10.1016/j.fct.2013.11.016] [PMID: 24275090]

He, S.Y.; Qian, Z.Y.; Tang, F.T.; Wen, N.; Xu, G.L.; Sheng, L. Effect of crocin on experimental atherosclerosis in quails and its mechanisms. Life Sci., 2005, 77(8), 907-921.
[http://dx.doi.org/10.1016/j.lfs.2005.02.006] [PMID: 15964309]

Li, J.; Lei, H.T.; Cao, L.; Mi, Y.N.; Li, S.; Cao, Y.X. Crocin alleviates coronary atherosclerosis via inhibiting lipid synthesis and inducing M2 macrophage polarization. Int. Immunopharmacol., 2018, 55, 120-127.
[http://dx.doi.org/10.1016/j.intimp.2017.11.037] [PMID: 29248792]

Lari, P.; Rashedinia, M.; Abnous, K.; Hosseinzadeh, H. Crocin improves lipid dysregulation in subacute diazinon exposure through ERK1/2 pathway in rat liver. Drug Res. (Stuttg.), 2014, 64(6), 301-305.
[http://dx.doi.org/10.1055/s-0033-1357196] [PMID: 24132704]

Paulis, G. Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapy. Res. Rep. Urol., 2018, 10, 75-87.
[http://dx.doi.org/10.2147/RRU.S170400] [PMID: 30271757]

Opdyke, D.L. Fragrance raw materials monographs. Chenopodium oil. Food Chem. Toxicol., 1976, 14, 713-715.

Huseini, H.F.; Anvari, M.S.; Khoob, Y.T.; Rabbani, S.; Sharifi, F.; Arzaghi, S.M.; Fakhrzadeh, H. Anti-hyperlipidemic and anti-atherosclerotic effects of Pinus eldarica Medw. nut in hypercholesterolemic rabbits. Daru, 2015, 23(1), 32.
[http://dx.doi.org/10.1186/s40199-015-0114-9] [PMID: 26054525]

de Lavor, É.M.; Fernandes, A.W.C.; de Andrade Teles, R.B.; Leal, A.E.B.P.; de Oliveira Júnior, R.G.; Gama, E. Silva, M.; de Oliveira, A.P.; Silva, J.C.; de Moura Fontes Araújo, M.T.; Coutinho, H.D.M.; de Menezes, I.R.A.; Picot, L.; da Silva Almeida, J.R.G. Essential oils and their major compounds in the treatment of chronic inflammation: A review of antioxidant potential in preclinical studies and molecular mechanisms. Oxid. Med. Cell. Longev., 2018, 20186468593
[http://dx.doi.org/10.1155/2018/6468593] [PMID: 30671173]

Jiang, Q.; Hao, R.; Wang, W.; Gao, H.; Wang, C. SIRT1/Atg5/autophagy are involved in the antiatherosclerosis effects of ursolic acid. Mol. Cell. Biochem., 2016, 420(1-2), 171-184.
[http://dx.doi.org/10.1007/s11010-016-2787-x] [PMID: 27514536]

Lv, Y.Y.; Jin, Y.; Han, G.Z.; Liu, Y.X.; Wu, T.; Liu, P.; Zhou, Q.; Liu, K.X.; Sun, H.J. Ursolic acid suppresses IL-6 induced C-reactive protein expression in HepG2 and protects HUVECs from injury induced by CRP. Eur. J. Pharm. Sci., 2012, 45(1-2), 190-194.
[http://dx.doi.org/10.1016/j.ejps.2011.11.002] [PMID: 22108347]

Ullevig, S.L.; Zhao, Q.; Zamora, D.; Asmis, R. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis, 2011, 219(2), 409-416.
[http://dx.doi.org/10.1016/j.atherosclerosis.2011.06.013] [PMID: 21752377]

Messner, B.; Zeller, I.; Ploner, C.; Frotschnig, S.; Ringer, T.; Steinacher-Nigisch, A.; Ritsch, A.; Laufer, G.; Huck, C.; Bernhard, D. Ursolic acid causes DNA-damage, p53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo. Atherosclerosis, 2011, 219(2), 402-408.
[http://dx.doi.org/10.1016/j.atherosclerosis.2011.05.025] [PMID: 21703625]

Li, Q.; Zhao, W.; Zeng, X. Hao, Zhihui. Ursolic acid attenuates atherosclerosis in ApoE−/− mice: role of LOX-1 mediated by ROS/NF-κB pathway. Molecules, 2018, 23(5), 1101.
[http://dx.doi.org/10.3390/molecules23051101] [PMID: 29735887]

Tannock, L.R. Ursolic acid effect on atherosclerosis: apples and apples, or apples and oranges? Atherosclerosis, 2011, 219(2), 397-398.
[http://dx.doi.org/10.1016/j.atherosclerosis.2011.09.029] [PMID: 21993411]

Ullevig, S.L.; Kim, H.S.; Nguyen, H.N.; Hambright, W.S.; Robles, A.J.; Tavakoli, S.; Asmis, R. Ursolic acid protects monocytes against metabolic stress-induced priming and dysfunction by preventing the induction of Nox4. Redox Biol., 2014, 2, 259-266.
[http://dx.doi.org/10.1016/j.redox.2014.01.003] [PMID: 24494201]

Zhang, Q.; Chang, Z.; Wang, Q. Ursane triterpenoids inhibit atherosclerosis and xanthoma in LDL receptor knockout mice. Cardiovasc. Drugs Ther., 2006, 20(5), 349-357.
[http://dx.doi.org/10.1007/s10557-006-0509-4] [PMID: 17136324]

Leng, S.; Iwanowycz, S.; Saaoud, F.; Wang, J.; Wang, Y.; Sergin, I.; Razani, B.; Fan, D. Ursolic acid enhances macrophage autophagy and attenuates atherogenesis. J. Lipid Res., 2016, 57(6), 1006-1016.
[http://dx.doi.org/10.1194/jlr.M065888] [PMID: 27063951]

Wang, Y.L.; Wang, Z.J.; Shen, H.L.; Yin, M.; Tang, K.X. Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit. Eur. J. Pharm. Sci., 2013, 50(3-4), 366-371.
[http://dx.doi.org/10.1016/j.ejps.2013.08.003] [PMID: 23954455]

Liu, D.S.; Gao, W.; Liang, E.S.; Wang, S.L.; Lin, W.W.; Zhang, W.D.; Jia, Q.; Guo, R.C.; Zhang, J.D. Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction. Eur. J. Pharmacol., 2013, 714(1-3), 163-169.
[http://dx.doi.org/10.1016/j.ejphar.2013.05.038] [PMID: 23792140]

Chan, J.Y.; Yuen, A.C.; Chan, R.Y.; Chan, S.W. A review of the cardiovascular benefits and antioxidant properties of allicin. Phytother. Res., 2013, 27(5), 637-646.
[http://dx.doi.org/10.1002/ptr.4796] [PMID: 22888009]

El-Gamal, E-K.M.M.; El-Gazzar, U.B.M. Biochemical therapeutic benefits of garlic on atherosclerosis induced by soybean in rats. Biochem. Mol. Biol. J., 2017, 3(19), 1-6.
[http://dx.doi.org/10.21767/2471-8084.100047 ]

Kim, J.; Lee, K.P.; Lee, D.W.; Lim, K. Piperine enhances carbohydrate/fat metabolism in skeletal muscle during acute exercise in mice. Nutr. Metab. (Lond.), 2017, 14(1), 43.
[http://dx.doi.org/10.1186/s12986-017-0194-2] [PMID: 28680454]

Matsuda, D.; Ohte, S.; Ohshiro, T.; Jiang, W.; Rudel, L.; Hong, B.; Si, S.; Tomoda, H. Molecular target of piperine in the inhibition of lipid droplet accumulation in macrophages. Biol. Pharm. Bull., 2008, 31(6), 1063-1066.
[http://dx.doi.org/10.1248/bpb.31.1063] [PMID: 18520030]

Wang, L.; Palme, V.; Rotter, S.; Schilcher, N.; Cukaj, M.; Wang, D.; Ladurner, A.; Heiss, E.H.; Stangl, H.; Dirsch, V.M.; Atanasov, A.G. Piperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP-1-derived macrophages. Mol. Nutr. Food Res., 2017, 61(4)1500960
[http://dx.doi.org/10.1002/mnfr.201500960] [PMID: 27862930]

Mueller, M.; Hobiger, S.; Jungbauer, A. Anti-inflammatory activity of extracts from fruits, herbs and spices. Food Chem., 2010, 122(4), 987-996.
[http://dx.doi.org/10.1016/j.foodchem.2010.03.041]

Son, D.J.; Kim, S.Y.; Han, S.S.; Kim, C.W.; Kumar, S.; Park, B.S.; Lee, S.E.; Yun, Y.P.; Jo, H.; Park, Y.H. Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling. Biochem. Biophys. Res. Commun., 2012, 427(2), 349-354.
[http://dx.doi.org/10.1016/j.bbrc.2012.09.061] [PMID: 22995306]

Bezerra, D.P.; Pessoa, C.; de Moraes, M.O.; Saker-Neto, N.; Silveira, E.R.; Costa-Lotufo, L.V. Overview of the therapeutic potential of piplartine (piperlongumine). Eur. J. Pharm. Sci., 2013, 48(3), 453-463.
[http://dx.doi.org/10.1016/j.ejps.2012.12.003] [PMID: 23238172]

Vazquez-Prieto, M.A.; Miatello, R.M. Organosulfur compounds and cardiovascular disease. Mol. Aspects Med., 2010, 31(6), 540-545.
[http://dx.doi.org/10.1016/j.mam.2010.09.009] [PMID: 20940019]

Evans, P.C. The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease. EPMA J., 2011, 2(1), 9-14.
[http://dx.doi.org/10.1007/s13167-011-0064-3] [PMID: 23199123]

Conzatti, A.; Fróes, F.C.; Schweigert Perry, I.D.; Souza, C.G.; Perry, S.; De Souza, C.G. Clinical and molecular evidence of the consumption of broccoli, glucoraphanin and sulforaphane in humans. Nutr. Hosp., 2014, 31(2), 559-569.
[http://dx.doi.org/10.3305/nh.2015.31.2.7685] [PMID: 25617536]

Kwon, J-S.; Joung, H.; Kim, Y.S.; Shim, Y.S.; Ahn, Y.; Jeong, M.H.; Kee, H.J. Sulforaphane inhibits restenosis by suppressing inflammation and the proliferation of vascular smooth muscle cells. Atherosclerosis, 2012, 225(1), 41-49.
[http://dx.doi.org/10.1016/j.atherosclerosis.2012.07.040] [PMID: 22898620]

Shehatou, G.S.G.; Suddek, G.M. Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits. Exp. Biol. Med. (Maywood), 2016, 241(4), 426-436.
[http://dx.doi.org/10.1177/1535370215609695] [PMID: 26490346]

Shehatou, G.S.G.; Suddek, G.M. Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits. Exp. Biol. Med. (Maywood), 2015, 2, 1-11.
[http://dx.doi.org/10.1177/1535370215609695] [PMID: 26490346]

Zhu, H.; Jia, Z.; Strobl, J.S.; Ehrich, M.; Misra, H.P.; Li, Y. Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress. Cardiovasc. Toxicol., 2008, 8(3), 115-125.
[http://dx.doi.org/10.1007/s12012-008-9020-4] [PMID: 18607771]

Hung, C.N.; Huang, H.P.; Wang, C.J.; Liu, K.L.; Lii, C.K. Sulforaphane inhibits TNF-α-induced adhesion molecule expression through the Rho A/ROCK/NF-κB signaling pathway. J. Med. Food, 2014, 17(10), 1095-1102.
[http://dx.doi.org/10.1089/jmf.2013.2901] [PMID: 25238321]

Juurlink, B.H.J. Dietary Nrf2 activators inhibit atherogenic processes. Atherosclerosis, 2012, 225(1), 29-33.
[http://dx.doi.org/10.1016/j.atherosclerosis.2012.08.032] [PMID: 22986182]

Huang, C.S.; Lin, A.H.; Liu, C.T.; Tsai, C.W.; Chang, I.S.; Chen, H.W.; Lii, C.K. Isothiocyanates protect against oxidized LDL-induced endothelial dysfunction by upregulating Nrf2-dependent antioxidation and suppressing NFκB activation. Mol. Nutr. Food Res., 2013, 57(11), 1918-1930.
[http://dx.doi.org/10.1002/mnfr.201300063] [PMID: 23836589]

Yoo, S.H.; Lim, Y.; Kim, S.J.; Yoo, K.D.; Yoo, H.S.; Hong, J.T.; Lee, M.Y.; Yun, Y.P. Sulforaphane inhibits PDGF-induced proliferation of rat aortic vascular smooth muscle cell by up-regulation of p53 leading to G1/S cell cycle arrest. Vascul. Pharmacol., 2013, 59(1-2), 44-51.
[http://dx.doi.org/10.1016/j.vph.2013.06.003] [PMID: 23810908]

Matsui, T.; Nakamura, N.; Ojima, A.; Nishino, Y.; Yamagishi, S-I. Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta. Nutr. Metab. Cardiovasc. Dis., 2016, 26(9), 797-807.
[http://dx.doi.org/10.1016/j.numecd.2016.04.008] [PMID: 27212619]

Panahi, Y.; Khalili, N.; Hosseini, M.S.; Abbasinazari, M.; Sahebkar, A. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Complement. Ther. Med., 2014, 22(5), 851-857.
[http://dx.doi.org/10.1016/j.ctim.2014.07.006] [PMID: 25440375]

Cicero, A.F.; Sahebkar, A.; Fogacci, F.; Bove, M.; Giovannini, M.; Borghi, C. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. Eur. J. Nutr., 2020, 59(2), 477-483.
[http://dx.doi.org/10.1007/s00394-019-01916-7] [PMID: 30796508]

Gao, W.; Sun, Y.; Cai, M.; Zhao, Y.; Cao, W.; Liu, Z.; Cui, G.; Tang, B. Copper sulfide nanoparticles as a photothermal switch for TRPV1 signaling to attenuate atherosclerosis. Nat. Commun., 2018, 9(1), 231.
[http://dx.doi.org/10.1038/s41467-017-02657-z] [PMID: 29335450]

El-Sheakh, A.R.; Ghoneim, H.A.; Suddek, G.M.; Ammar, E.S.M. Attenuation of oxidative stress, inflammation and endothelial dysfunction in hypercholesterolemic rabbits by allicin. Can. J. Physiol. Pharmacol., 2016, 94(2), 216-224.
[http://dx.doi.org/10.1139/cjpp-2015-0267] [PMID: 26618400]

Liu, D.S.; Wang, S.L.; Li, J.M.; Liang, E.S.; Yan, M.Z.; Gao, W. Allicin improves carotid artery intima-media thickness in coronary artery disease patients with hyperhomocysteinemia. Exp. Ther. Med., 2017, 14(2), 1722-1726.
[http://dx.doi.org/10.3892/etm.2017.4698] [PMID: 28810641]

Vijayakumar, R.S.; Surya, D.; Senthilkumar, R.; Nalini, N. Hypolipidemic effect of black pepper (Piper nigrum Linn.) in rats fed high fat diet. J. Clin. Biochem. Nutr., 2002, 32, 31-42.
[http://dx.doi.org/10.3164/jcbn.32.31]

Chen, S.; Tang, Y.; Qian, Y.; Chen, R.; Zhang, L.; Wo, L.; Chai, H. Allicin prevents H₂O₂-induced apoptosis of HUVECs by inhibiting an oxidative stress pathway. BMC Complement. Altern. Med., 2014, 14(1), 321.
[http://dx.doi.org/10.1186/1472-6882-14-321] [PMID: 25174844]

Gonen, A.; Harats, D.; Rabinkov, A.; Miron, T.; Mirelman, D.; Wilchek, M.; Weiner, L.; Ulman, E.; Levkovitz, H.; Ben-Shushan, D.; Shaish, A. The antiatherogenic effect of allicin: possible mode of action. Pathobiology, 2005, 72(6), 325-334.
[http://dx.doi.org/10.1159/000091330] [PMID: 16582584]

Park, S.H.; Sung, Y.Y.; Nho, K.J.; Kim, H.K. Protective activity ethanol extract of the fruits of Illicium verum against atherogenesis in apolipoprotein E knockout mice. BMC Complement. Altern. Med., 2015, 15(1), 232.
[http://dx.doi.org/10.1186/s12906-015-0750-0] [PMID: 26174316]

de Cássia da Silveira, E. Sá, R.; Andrade, L.N.; de Oliveira, R.D.R.B.; de Sousa, D.P. A review on anti-inflammatory activity of phenylpropanoids found in essential oils. Molecules, 2014, 19(2), 1459-1480.
[http://dx.doi.org/10.3390/molecules19021459] [PMID: 24473208]

Aggarwal, B.B.; Prasad, S.; Reuter, S.; Kannappan, R.; Yadev, V.R.; Park, B.; Kim, J.H.; Gupta, S.C.; Phromnoi, K.; Sundaram, C.; Prasad, S.; Chaturvedi, M.M.; Sung, B. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: “reverse pharmacology” and “bedside to bench” approach. Curr. Drug Targets, 2011, 12(11), 1595-1653.
[http://dx.doi.org/10.2174/138945011798109464] [PMID: 21561421]

Chuengsamarn, S.; Rattanamongkolgul, S.; Phonrat, B.; Tungtrongchitr, R.; Jirawatnotai, S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J. Nutr. Biochem., 2014, 25(2), 144-150.
[http://dx.doi.org/10.1016/j.jnutbio.2013.09.013] [PMID: 24445038]

Daneshi-Maskooni, M.; Keshavarz, S.A.; Mansouri, S.; Qorbani, M.; Alavian, S.M.; Badri-Fariman, M.; Jazayeri-Tehrani, S.A.; Sotoudeh, G. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial. Trials, 2017, 18(1), 260.
[http://dx.doi.org/10.1186/s13063-017-1979-3] [PMID: 28592311]

Murad, S.; Khokhar, A.Q.; Marwat, I.U.R.; Saif, S.; Abbasi, G.M.; Shafique, A.; Ghaffar, A. Flavoring agents used in cuisine may be used as treatment of disease. Int. J. Res. Pharm. Biosci., 2019, 6(7), 14-17.